| Tag | Content |
|---|
EnhancerAtlas ID | HS093-13417 |
Organism | Homo sapiens |
Tissue/cell | HL-60 |
Coordinate | chr17:66308410-66309180 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| SPI1 | MA0080.4 | chr17:66308570-66308584 | AACTTCCGCTTTCA | - | 6.3 | | SPIB | MA0081.2 | chr17:66308570-66308582 | AACTTCCGCTTT | - | 6.22 | | Zfx | MA0146.2 | chr17:66309162-66309176 | GAGGCCGAGGCGGG | - | 6.01 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09251 | chr17:66305869-66313289 | CD14 | | SE_34520 | chr17:66308079-66309665 | HCT-116 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I068311 | chr17 | 66307639 | 66311781 |
|
Enhancer Sequence | ATAAATATTT GTTCATCAAT AAATGGGCTC TAGGAGCTCA AGATGCCCTG GAATGTCACC 60
CCAAATTTTG CATGTAGGAA TACTTTTCTG GGGAGAGAGT TCATCCATTC ATGAACATTT 120
ACCAGATTCT CCAAAGGGCG TGGGTTGCCA AATGCTTAGG AACTTCCGCT TTCAGTGTTT 180
AGCAGGTTAG CGGGGAAATA TTAGTCCCAT TATTTAAGCT GAGATTTGCG AGGCCTACAC 240
GTTTTTTTTT TCTCATGTGC TGTCTCTACT GTCACACTCT CATCCTGAGC AGAAAGGAGG 300
ACTCAGGGGT CAGATGCCAA ATGTGGTTCG TTGGGCTCTC CTTCTCCCCA CCCCCTTATG 360
AAAGTGTTTC TTTCCATCTG AGCCTTGTGA CAGTGGCCAG GTGGCTAGCC CTCTGGCCTG 420
AGGTCGACGG CTTTTCATTC TTCTTTGTTG ACAGGAAAGC CGGGCTTCCT GTGAGGCCAT 480
GAACTGATTC ATCGCTGGTT TCTCCCACTG CCTACTCACG GCCAGTGGGG AACCATGACT 540
TTCAGACACG AACTCTTATT GCCCAACAGG GTCTGGGGTG ACTAGCTGGG ACTGCACGCT 600
CAAGCCACCA CGCCCGGTTC TGTTGCCTCC TTTTTATTTG TGCATGAATT TTCTAGGACT 660
GCTGGAACAA ATTACTCCAA ACTGGACAGC TTAAAATGTT ACTTTGTTCT GGCCAGGCAC 720
AGTGGCTCAC ACCTGTAATC CCAGCACTTT GGGAGGCCGA GGCGGGCAGA 770
|
